Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes

ABSTRACT Initiation of the Epstein-Barr virus (EBV) lytic cycle is controlled by two immediate-early genes, BZLF1 and BRLF1. In certain epithelial and B-cell lines, their protein products, ZEBRA and Rta, stimulate their own expression, reciprocally stimulate each other’s expression, and activate downstream viral targets. It has been difficult to examine the individual roles of these two transactivators in EBV-infected lymphocytes, as they are expressed simultaneously upon induction of the lytic cycle. Here we show that the Burkitt lymphoma cell line Raji represents an experimental system that allows the study of Rta’s role in the lytic cycle of EBV in the absence and presence of ZEBRA. When expressed in Raji cells, exogenous Rta does not activate endogenous BZLF1 expression, yet Rta remains competent to transactivate certain downstream viral targets. Some genes, such as BaRF1, BMLF1, and a late gene, BLRF2, are maximally activated by Rta itself in the absence of detectable ZEBRA. The use of the Z(S186A) mutant form of ZEBRA, whose transactivation function is manifest only by coexpression of Rta, allows identification of a second class of lytic cycle genes, such as BMRF1 and BHRF1, that are activated in synergy by Rta and ZEBRA. It has already been documented that of the two activators, only ZEBRA stimulates the BRLF1 gene in Raji cells. Thus, there is a third class of viral genes activated by ZEBRA but not Rta. Moreover, ZEBRA exhibits an inhibitory effect on Rta’s capacity to stimulate the late gene, BLRF2. Consequently ZEBRA may function to repress Rta’s potential to activate some late genes. Raji cells thus allow delineation of the combinatorial roles of Rta and ZEBRA in control of several distinct classes of lytic cycle genes.

[1]  T. Ragoczy,et al.  Amino Acid Substitutions Reveal Distinct Functions of Serine 186 of the ZEBRA Protein in Activation of Early Lytic Cycle Genes and Synergy with the Epstein-Barr Virus R Transactivator , 1999, Journal of Virology.

[2]  S. Kenney,et al.  Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. , 1998, Virology.

[3]  T. Ragoczy,et al.  The Epstein-Barr Virus Rta Protein Activates Lytic Cycle Genes and Can Disrupt Latency in B Lymphocytes , 1998, Journal of Virology.

[4]  M. Carey,et al.  Compensatory Energetic Relationships between Upstream Activators and the RNA Polymerase II General Transcription Machinery* , 1998, The Journal of Biological Chemistry.

[5]  G. Miller,et al.  Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis , 1997, Journal of virology.

[6]  L. Gradoville,et al.  Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency , 1997, Journal of virology.

[7]  S. Kenney,et al.  The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter , 1997, Journal of virology.

[8]  G. Suske,et al.  Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter. , 1997, Virology.

[9]  E. Flemington,et al.  G0/G1 Growth Arrest Mediated by a Region Encompassing the Basic Leucine Zipper (bZIP) Domain of the Epstein-Barr Virus Transactivator Zta* , 1996, The Journal of Biological Chemistry.

[10]  R. Sun,et al.  Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21) , 1996, Journal of virology.

[11]  S. Kenney,et al.  Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Strominger,et al.  Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction , 1996, Journal of virology.

[13]  E. Flemington,et al.  The Epstein‐Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin‐dependent kinase inhibitors. , 1996, The EMBO journal.

[14]  L. Corbo,et al.  Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. , 1996, The Journal of general virology.

[15]  J. Countryman,et al.  Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras , 1996, Journal of virology.

[16]  T. Ooka,et al.  The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame , 1995, Journal of virology.

[17]  M. Marschall,et al.  Different activation of Epstein-Barr virus immediate-early and early genes in Burkitt lymphoma cells and lymphoblastoid cell lines , 1994, Journal of virology.

[18]  W. Hammerschmidt,et al.  A transcription factor with homology to the AP‐1 family links RNA transcription and DNA replication in the lytic cycle of Epstein‐Barr virus. , 1993, The EMBO journal.

[19]  W. Hammerschmidt,et al.  cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus , 1993, Journal of virology.

[20]  E. van Heerde,et al.  Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins , 1993, Journal of virology.

[21]  M. Carey,et al.  Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA , 1992, Journal of virology.

[22]  I. Mellinghoff,et al.  Early events in Epstein-Barr virus genome expression after activation: regulation by second messengers of B cell activation. , 1991, Virology.

[23]  D. Dorsky,et al.  Cooperation of EBV DNA polymerase and EA-D(BMRF1) in vitro and colocalization in nuclei of infected cells. , 1991, Virology.

[24]  P. Farrell,et al.  Pathways of activation of the Epstein-Barr virus productive cycle , 1991, Journal of virology.

[25]  J. Nicolas,et al.  Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required. , 1991, Nucleic acids research.

[26]  H. Sato,et al.  Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines , 1990, Journal of virology.

[27]  E. Flemington,et al.  Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1 , 1990, Journal of virology.

[28]  J. Hardwick,et al.  An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators , 1990, Journal of virology.

[29]  M. Buisson,et al.  The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R , 1989, Journal of virology.

[30]  D. Markovitz,et al.  The Epstein-Barr virus immediate-early gene product, BMLF1, acts in trans by a posttranscriptional mechanism which is reporter gene dependent , 1989, Journal of virology.

[31]  C. Rooney,et al.  The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle , 1989, Journal of virology.

[32]  J. Giot,et al.  Epstein‐Barr virus bicistronic mRNAs generated by facultative splicing code for two transcriptional trans‐activators. , 1989, The EMBO journal.

[33]  S. Altman,et al.  Identification and characterization of an RNA molecule that copurifies with RNase P activity from HeLa cells. , 1989, Genes & development.

[34]  G. Miller,et al.  Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency. , 1988, Virology.

[35]  P. Lieberman,et al.  A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen , 1988, Journal of virology.

[36]  B. Barrell,et al.  Sequence analysis of Raji Epstein-Barr virus DNA. , 1988, Virology.

[37]  E. Huang,et al.  Transfer and Expression of Plasmids Containing Human Cytomegalovirus Immediate‐Early Gene 1 Promoter‐Enhancer Sequences in Eukaryotic and Prokaryotic Cells , 1988, Biotechnology and applied biochemistry.

[38]  M. Perricaudet,et al.  Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells , 1987, Journal of virology.

[39]  E. Kieff,et al.  Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex. , 1987, Virology.

[40]  R. S. Tan,et al.  Association of Epstein-Barr virus early antigen diffuse component and virus-specified DNA polymerase activity , 1987, Journal of virology.

[41]  L. Heston,et al.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Barrell,et al.  Coding content and expression of the EBV B95-8 genome in the region from base 62,248 to base 82,920. , 1986, Virology.

[43]  M. Ptashne A Genetic Switch: Gene Control and Phage Lambda , 1986 .

[44]  K. Takada,et al.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment , 1986, Journal of virology.

[45]  J. Countryman,et al.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. L. Deininger,et al.  DNA sequence and expression of the B95-8 Epstein—Barr virus genome , 1984, Nature.

[47]  B. Barrell,et al.  Homology between two EBV early genes and HSV ribonucleotide reductase and 38K genes. , 1984, Nucleic acids research.

[48]  B. Barrell,et al.  Transcription and DNA sequence of the BamHI L fragment of B95‐8 Epstein‐Barr virus. , 1984, The EMBO journal.

[49]  A. Polack,et al.  Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji. , 1984, Virology.

[50]  E. Kieff,et al.  Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies , 1983, Journal of virology.

[51]  L. Heston,et al.  Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Hausen,et al.  Persisting oncogenic herpesvirus induced by the tumour promoter TPA , 1978, Nature.

[53]  R. Pulvertaft,et al.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA). , 1964, Lancet.

[54]  T. Chatila,et al.  Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member , 1997, The EMBO journal.

[55]  M. Ptashne A genetic switch : phage λ and higher organisms , 1992 .

[56]  J. Kolman,et al.  Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  G. Miller,et al.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.